Deepak Mital, MD
Transplant Surgery · Oak Lawn, ILNPI 1720024219
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (57.7%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. Veloxis Pharmaceuticals, Inc. accounts for 97.8% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2019 at $30,557 and has fallen 99.8% since, to $50 in 2025. Among transplant surgery clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 114 payments — averaging $492.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Veloxis Pharmaceuticals, Inc.$55K
- AstraZeneca$196
- E.r. Squibb & Sons, L.L.C.$188
- W. L. Gore & Associates, Inc.$131
- Takeda Pharmaceuticals U.S.A., Inc.$127
- One Lambda, Inc.$119
- plus $502 from 9 others
What the payments were for
- Consulting fees$18,00032%
- Speaking & faculty fees$1,5253%
- Travel & lodging$32,39258%
- Food & beverage$4,2228%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Veloxis Pharmaceuticals, Inc. | 86 | $54,876 |
| AstraZeneca | 4 | $196 |
| E.r. Squibb & Sons, L.L.C. | 10 | $188 |
| W. L. Gore & Associates, Inc. | 1 | $131 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $127 |
| One Lambda, Inc. | 1 | $119 |
| AbbVie | 1 | $97 |
| Amgen | 1 | $85 |
| Mallinckrodt Hospital Products Inc. | 2 | $81 |
| Sanofi | 1 | $77 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $68 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
| Sanofi-aventis U.S. LLC | 1 | $25 |
| Mallinckrodt Enterprises LLC | 1 | $25 |
| KCI USA, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Envarsus$83,441
- PROPATEN Vascular Graft$131
- LIVTENCITY$106
How this compares
$56,139 in reported general payments places this provider in the 90th percentile of 52 transplant surgery providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other transplant surgery in Oak Lawn
- Piotr WitkowskiChicago$235K
- Vinayak RohanChicago$95K
- John FungChicago$95K
- Talia BakerChicago$51K
- Joseph LeventhalChicago$25K
- Lloyd BrownChicago$16K
- Daniel Borja CachoChicago$15K
- Diego di SabatoMaywood$13K
- Oyedolamu OlaitanChicago$11K
- Mario SpaggiariChicago$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.